QIAGEN NV (QGEN)
47.65
-1.18
(-2.42%)
USD |
NYSE |
Mar 03, 16:00
47.88
+0.23
(+0.48%)
Pre-Market: 07:24
QIAGEN Price : 47.65 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InflaRx NV | 0.9124 |
| CDT Equity, Inc. | 0.62 |
| LENZ Therapeutics, Inc. | 13.15 |
| Liminatus Pharma, Inc. | 0.2302 |
| Oruka Therapeutics, Inc. | 32.84 |
Price Related Metrics
| PE Ratio | 23.31 |
| PS Ratio | 4.741 |
| PEG Ratio | 0.0556 |
| Price to Book Value | 2.598 |
| Price to Free Cash Flow | 22.16 |
| Earnings Yield | 4.29% |
| Market Cap | 9.816B |
| PEGY Ratio | 0.0546 |
| Operating PE Ratio | 18.99 |